Strength
30 mg/1
Manufacturer
Amgen Inc.NDC
55513013760
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/7/2026
Active Ingredients
APREMILASTApproval Type
New Drug (NDA)
FDA Application
NDA205437On Market Since
2/26/2020
Pharmacological Classes
Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
EUCRISA 2% OINTMENT
Brand
55724021111•Pfizer Inc.
$10.6810
per GM
EUCRISA 2% OINTMENT
Brand
55724021121•Pfizer Inc.
$12.6464
per GM
DALIRESP 250 MCG TABLET
Brand
00310008828•AstraZeneca Pharmaceuticals LP
$14.9826
per EA
DALIRESP 250 MCG TABLET
Brand
00310008839•AstraZeneca Pharmaceuticals LP
$14.9826
per EA
DALIRESP 500 MCG TABLET
Brand
00310009530•AstraZeneca Pharmaceuticals LP
$15.0027
per EA
DALIRESP 500 MCG TABLET
Brand
00310009590•AstraZeneca Pharmaceuticals LP
$15.0027
per EA
ZORYVE 0.15% CREAM
Brand
80610011560•Arcutis Biotherapeutics, Inc.
$15.3893
per GM
ZORYVE 0.3% CREAM
Brand
80610013060•Arcutis Biotherapeutics, Inc.
$15.3897
per GM
ZORYVE 0.3% FOAM
Brand
80610043060•Arcutis Biotherapeutics, Inc.
$15.3897
per GM